ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus

If a patient with diabetes has the option to take their medication by needle versus an oral pill, they are most likely to choose the pill. But what if the price of the pill was so high that it might be more cost-effective for patients to use the needle?